Trial intelligence / Profile preview

Subgam SC in Primary Antibody Deficiency

NCT02247141Phase 3Completed

Sponsor
Bio Products Laboratory
Start
Jun 2000
Primary completion
Jan 2005
Modality
Biologic
Countries
1
01

Overview

A Phase 3 trial of Subgam in Primary antibody deficiency (PAD), sponsored by Bio Products Laboratory. Started Jun 2000; status: completed.

02

Drugs

Subgam
03

Conditions

Primary antibody deficiency (PAD)

Beyond the preview

Go deeper on NCT02247141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02247141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call